VAV proteins as signal integrators for multi-subunit immune-recognition receptors

Nature Reviews Immunology

Volumn 2, Issue 7, 2002, Pages 476-486

  Turner, Martin ^a   Billadeau, Daniel D ^b  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; RAC PROTEIN; RHO FACTOR; VAV PROTEIN; CELL CYCLE PROTEIN; IMMUNOGLOBULIN RECEPTOR; ONCOPROTEIN; VAV1 PROTEIN, HUMAN;

ANTIGEN RECOGNITION; B LYMPHOCYTE; CELL MATURATION; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; MAST CELL DEGRANULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; HUMAN; LYMPHOCYTE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL CYCLE PROTEINS; HUMANS; LYMPHOCYTES; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036631548     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri840     Document Type: Review

References (117)

1. Bishop, A. B. & Hall, A. Rho GTPases and their effector proteins. Biochem. J. 348, 241-255 (2000).
2. Bustelo, X. R. Vav proteins, adaptors and cell signalling. Oncogene 20, 6372-6381 (2001).
3. Henning, S. & Cleverley, S. Small GTPases in lymphocyte biology - Rho proteins take center stage. Immunol. Res. 20, 29-42 (1999).
4. Deckert, M., Tartare-Deckert, S., Couture, C. & Altman, A. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene. Immunity 5, 591-604 (1996).
5. Han, J. et al. Lck regulates Vav activation of members of the Rho family of GTPases. Mol. Cell. Biol. 17, 1346-1353 (1997).
6. Schuebel, K. E., Movilla, N., Rosa, J. L. & Bustelo, X. R. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J. 17, 6608-6621 (1998).
7. Michel, F., Grimaud, L., Tuosto, L. & Acuto, O. Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells. J. Biol. Chem. 273, 31932-31938 (1998).
8. Huang, J., Tilly, D., Altman, A., Sugie, K. & Grey, H. M. T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase. Proc. Natl Acad. Sci. USA 97, 10923-10929 (2000).
9. Aghazadeh, B., Lowry, W. E., Huang, X.-Y. & Rosen, M. Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 102, 625-633 (2000). This paper describes a unique mechanism for the activation of the enzymatic function of VAV1.
10. Lopez-Lago, M., Lee, H., Cruz, C., Movilla, N. & Bustelo, X. R. Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. Mol. Cell. Biol. 20, 1678-1691 (2000).
11. Billadeau, D. D., Mackie, S. M., Schoon, R. A. & Leibson, P. J. Specific subdomains of Vav differentially affect T-cell and NK-cell activation. J. Immunol. 164, 3971-3981 (2000).
12. Kuhne, M. R., Ku, G. & Weiss, A. A guanine nucleotide exchange factor-independent function of Vav-1 in transcriptional activation. J. Biol. Chem. 275, 2185-2190 (2000).
13. Bustelo, X. R. Regulatory and signalling properties of the Vav family. Mol. Cell. Biol. 20,1461-1477 (2000).
14. Koretzky, G. A. & Myung, P. S. Positive and negative regulation of T-cell activation by adaptor proteins. Nature Rev. Immunol. 1, 95-107 (2001).
15. Tuosto, L., Michel, F. & Acuto, O. p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 184, 1161-1166 (1996).
16. Tartare-Deckert, S. et al. Vav2 activates c-Fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocytes. J. Biol. Chem. 276, 20849-20857 (2001).
17. Fu, C. & Chan, A. C. Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cγ, Grb2 and Vav after B-cell antigen receptor activation. J. Biol. Chem. 272, 27362-27368 (1997).
18. Myung, P. S. et al. Differential requirement for SLP-76 domains in T-cell development and function. Immunity 15, 1011-1026 (2001).
19. Nunes, J. A., Collette, Y., Truneh, A., Olive, D. & Cantrell, D. A. The role of p21 ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21 ras. J. Exp. Med. 180, 1067-1076 (1994).
20. Klasen, S., Pages, F., Peyron, J.-F., Cantrell, D. A. & Olive, D. Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein. Int. Immunol. 10, 481-489 (1998).
21. Hehner, S. P., Hofmann, T. G., Dienz, O., Droge, W. & Schmitz, M. L. Tyrosine-phosphorylated Vav1 as a point of integration for T-cell-receptor- and CD28-mediated activation of JNK, p38 and interleukin-2 transcription. J. Biol. Chem. 275, 18160-18171 (2000).
22. Raab, M., Pfister, S. & Rudd, C. E. CD28 signalling via Vav/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 15, 921-933 (2001).
23. Weng, W. K., Jarvis, L. & LeBien, T. W. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19A/av/phosphatidylinositol 3-kinase complex in human B-cell precursors. J. Biol. Chem. 269, 32514-32521 (1994).
24. O'Rourke, L. et al. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8, 635-645 (1998).
25. Doody, G. M. et al. Vav-2 controls NFAT-dependent transcription in B but not T lymphocytes. EMBO J. 19, 6173-6184 (2000).
26. Sato, S., Jansen, P. J., & Tedder, T. F. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B-lymphocyte signalling. Proc. Natl Acad. Sci. USA 94, 13158-13162 (1997).
27. Fujimoto, M. et al. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 13, 47-57 (2000).
28. Finco, T. S., Kadlecek, T., Zhang, W., Samelson, L. E. & Weiss, A. LAT is required for the TCR-mediated activation of PLCγ1 and the Ras pathway. Immunity 9, 617-826 (1998).
29. Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. & Samelson, L. LAT: the ZAP-70 tyrosine kinase substrate that links T-cell receptor to cellular activation. Cell 92, 83-92 (1998).
30. Songyang, Z. et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk and Vav. Mol. Cell. Biol. 14, 2777-2785 (1994).
31. Ye, Z. S. & Baltimore, D. Binding of Vav to Grb2 through dimerization of Src-homology 3 domains. Proc. Natl Acad. Sci. USA 91, 12629-12633 (1994).
32. Nishida, M. et al. Novel recognition mode between Vav and Grb2 SH3 domains. EMBO J. 20, 2995-3007 (2001).
33. Katzav, S., Cleveland, J. L., Heslop, H. E. & Pulido, D. Loss of the amino-terminal helix-loop-helix domain of the Vav proto-oncogene activates its transforming potential. Mol. Cell. Biol. 11, 1912-1920 (1991).
34. Movilla, N. & Bustelo, X. R. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol. Cell. Biol. 19, 7870-7885 (1999).
35. Han, J. et al. Role of substrates and products of PI3-kinase in regulating activation of Rac-related guanosine triphosphates by Vav. Science 279, 558-560 (1998).
36. Das, B. et al. Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and SOS1 regulates Rac binding. J. Biol. Chem. 275, 15074-15081 (2000).
37. Fang, D. & Liu, Y.-C. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nature Immunol. 2, 870-875 (2001).
38. Djouder, N. et al. Rac and phosphatidylinositol 3-kinase regulate the protein kinase B in FcεRI signalling in RBL 2H3 mast cells. J. Immunol. 166, 1627-1634 (2001).
39. Inabe, K. et al. Vav3 modulates B-cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195, 189-200 (2002). References 38 and 39 show that the activation of VAV is not dependent on PI3K.
40. Billadeau, D. D., Mackie, S. M., Schoon, R. A. & Leibson, P. J. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity. J. Exp. Med. 192, 381-391 (2000).
41. Villalba, M. et al. A novel functional interaction between Vav and PKCθ is required for TCR-induced T-cell activation. Immunity 12, 151-160 (2000).
42. Ferguson, K. M. et al. Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains. Mol. Cell. 6, 373-384 (2000).
43. Lietzke, S. E. et al. Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains. Mol. Cell. 6, 385-394 (2000).
44. Isakoff, S. J. et al. Identification and analysis of PH domain-containing targets of phosphatidylinositol 3-kinase using a novel in vivo assay in yeast. EMBO J. 17, 5374-5387 (1998).
45. Zheng, Y. Dbl family guanine nucleotide exchange factors. Trends Biochem. Sci. 26, 724-732 (2001).
46. Billadeau, D. D. et al. The Vav-Rac pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188, 549-559 (1998).
47. Crespo, P. et al. Rac-1-dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 13, 455-460 (1996).
48. Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S. & Bustelo, X. R. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the Vav proto-oncogene product. Nature 385, 169-172 (1997).
49. Meffre, E., Casellas, R. & Nussenzweig, M. C. Antibody regulation of B-cell development. Nature Immunol. 1, 379-385 (2000).
50. Doody, G. M. et al. Signal transduction through Vav-2 participates in humoral immune responses and B-cell maturation. Nature Immunol. 2, 542-547 (2001).
51. Tedford, K. et al. Compensation betwenn Vav1 and Vav2 in B-cell receptor development and antigen-receptor signalling. Nature Immunol. 2, 548-555 (2001). References 50 and 51 describe the redundant and non-redundant roles of Vav proteins in lymphocytes using mouse models.
52. Glassford, J. et al. Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen receptor. J. Biol. Chem. 276, 41040-41048 (2001).
53. Tarakhovsky, A. et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374, 467-470 (1995).
54. Zhang, R., Alt, F. W., Davidson, L., Orkin, S. H. & Swat, W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374, 470-473 (1995).
55. Gulbranson-Judge, A. et al. Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T-cell help. Eur. J. Immunol. 29, 477-487 (1999).
56. Fehling, H. J. & von Boehmer, H. Early αβ T-cell development in the thymus of normal and genetically altered mice. Curr. Opin. Immunol. 9, 263-275 (1997).
57. + thymocytes. Nature 374, 474-477 (1995).
58. Turner, M. et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7, 451-460 (1997).
59. Gomez, M., Tybulewicz, V. & Cantrell, D. A. Control of pre-T-cell proliferation and differentiation by the GTPase Rac-1. Nature Immunol. 1, 348-352 (2000).
60. Corre, I., Gomez, M., Vielkind, S. & Cantrell, D. A. Analysis of thymocyte development reveals that the GTPase RhoA is a positive regulator of T-cell receptor responses in vivo. J. Exp. Med. 194, 903-913 (2001).
61. Fischer, K. D. et al. Vav is a regulator of cytoskeletal reorganisation mediated by the T-cell receptor. Curr. Biol. 8, 554-562 (1998).
62. Chan, G., Hanke, T. & Fischer, K.-D. Vav1 regulates NK T-cell development and NK-cell cytotoxicity. Eur. J. Immunol. 31, 2403-2410 (2001).
63. Holsinger, L. J. et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8, 563-572 (1998). This reference, together with reference 62, was the first to document cytoskeletal impairment in Vav1-deficient T cells.
64. Costello, P. S. et al. The Rho-family GTP exchange factor Vav is a critical transducer of T-cell receptor signals to the calcium, ERK and NF-κB pathways. Proc. Natl Acad. Sci. USA 96, 3035-3040 (1999).
65. Kong, Y. Y. et al. Vav regulates peptide-specific apoptosis in thymocytes. J. Exp. Med. 188, 2099-2111 (1998).
66. Moores, S. L. et al. Vav family proteins couple to diverse cell-surface receptors. Mol. Cell. Biol. 20, 6364-6373 (2000).
67. Krawczyk, C. et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 13, 463-473 (2000).
68. Bachmann, M. F. et al. The guanine-nucleotide exchange factor Vav is a crucial regulator of B-cell receptor activation and B-cell responses to non-repetitive antigens. J. Immunol. 163, 137-142 (1999).
69. Penninger, J. M. et al. The oncogene product Vav is a crucial regulator of primary cytotoxic T-cell responses but has no apparent role in CD28-mediated co-stimulation. Eur. J. Immunol. 29, 1709-1718 (1999).
70. Raulet, D. H., Vance, R. E. & McMahon, C. W. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19, 291-331 (2001).
71. Galandrini, R., Palmieri, G., Piccloi, M., Fragati, L. & Santoni, A. Role for the Rac1 exchange factor Vav in the signalling pathways leading to NK-cell cytotoxicity. J. Immunol. 162, 3148-3152 (1999).
72. Jiang, K. et al. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nature Immunol. 1, 419-425 (2000).
73. Colucci, F. et al. Functional dichotomy in NK-cell signalling: Vav1-dependent and -independent mechanisms. J. Exp. Med. 193, 1413-1424 (2001).
74. Wedemeyer, J., Tsai, M. & Galli, S. J. Roles of mast cells in innate and acquired immunity. Curr. Opin. Immunol. 12, 624-631 (2000).
75. 3 in Vav1-deficient mast cells.
76. Liu, B. P. & Burridge, K. Vav2 activates Rac1, Cdc42 and RhoA downstream from growth-factor receptors but not β1-integrins. Mol. Cell. Biol. 20, 7160-7169 (2000).
77. Abe, K. et al. Vav2 is an activator of Cdc42, Rac1 and RhoA. J. Biol. Chem. 275, 10141-10149 (2000).
78. Mangnani, P. A. & Carpenter, C. L. Vav2 is required for cell spreading. J. Cell. Biol. 154, 177-186 (2001).
79. Movilla, N., Dosil, M., Zheng, Y. & Bustelo, X. R. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42. Oncogene 20, 8057-8065 (2001).
80. Reynolds, L. F. et al. Vav1 transduces T-cell receptor signals to the activation of phospholipase Cγ1 via phosphoinositide-3-kinase-dependent and -independent pathways. J. Exp. Med. 195, 1103-1114 (2002). Together with references 39 and 75, this study documents the impairment of the PI3K-Tec axis in Vav-deficient cells.
81. Wulfing, C., Bauch, A., Crabtree, G. R. & Davis, M. M. The Vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface. Proc. Natl Acad. Sci. USA 97, 10150-10155 (2000).
82. Villalba, M. et al. Vav1/Rac-dependent actin cytoskeleton reorganisation is required for lipid-raft clustering in T cells. J. Cell. Biol. 155, 331-338 (2001).
83. Lee, K. et al. T-cell receptor signalling precedes immunological synapse formation. Science 295, 1539-1542 (2002).
84. Kaminuma, O., Deckert, M., Elly, C., Liu, Y. & Altman, A. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter. Mol. Cell. Biol. 21, 3126-3136 (2001).
85. Wu, J., Katzav, S. & Weiss, A. A functional T-cell receptor signaling pathway is required for p95vav activity. Mol. Cell. Biol. 15, 4337-4346 (1995).
86. 2-terminal sequences in the negative regulatiuon of Vav signalling and transforming activity. J. Biol. Chem. 274, 30410-30418 (1999).
87. Lin, X., O'Mahoney, A., Geleziunas, R. & Greene, W. C. Protein kinase Cθ participates in NF-κB/Rel activation induced by CD3/CD28 costimulation through selective activation of IκBβ (IKKβ). Mol. Cell. Biol. 20, 2933-2940 (2000).
88. Coudronniere, N., Villalba, M., Englund, N. & Alyman, A. NF-κB activation induced by CD28 costimulation is mediated by PKCθ. Proc. Natl Acad. Sci. USA 97, 3394-3399 (2000).
89. Teramoto, H., Salem, P., Robbins, K., Bustelo, X. & Gutkind, J. Tyrosine phosphorylation of the Vav proto-oncogene product links FcεRI to the Rac1-JNK pathway. J. Biol. Chem. 272, 10751-10755 (1997).
90. Song, J. S. et al. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/JNK-dependent pathway. J. Immunol. 163, 802-810 (1999).
91. Sun, Z. et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404, 402-407 (2000).
92. Bakash, S. & Burakoff, S. J. The role of calcineurin in lymphocyte activation. Semin. Immunol. 12, 405-415 (2000).
93. Tollas, K. F., Cantley, L. C. & Carpenter, C. L. Rho family GTPases bind to phosphoinositide kinases. J. Biol. Chem. 270, 17656-17659 (1995).
94. Nisitani, S., Kato, R. M., Rawlings, D. J., Witte, O. N. & Wahl, M. I. In situ detection of activated Bruton's tyrosine kinase in the Ig signalling complex by phosphopeptide-specific monoclonal antibodies. Proc. Natl Acad. Sci. USA 96, 2221-2226 (1999).
95. Lewis, C. M., Broussard, C., Czar, M. J. & Schwartzberg, P. L. Tec kinases: modulators of lymphocyte signalling and development. Curr. Opin. Immunol. 13, 317-325 (2001).
96. Shigematsu, H. et al. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J. Biol. Chem. 272, 14334-14340 (1997).
97. Bertagnolo, V., Marchisio, M., Violina, S., Caramelli, E. & Capitani, S. Nuclear association of tyrosine-phosphorylated Vav to phospholipase Cγ1 and phosphoinositide 3-kinase during granulocytic differentiation of HL-60 cells. FEBS Lett. 441, 480-484 (1998).
98. Zeng, L. et al. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity modulates cell morphology and induces cell transformation. Mol. Cell. Biol. 20, 9212-9224 (2000).
99. Bokoch, G. M., Vlahos, C. J., Wang, Y., Knaus, U. G. & Traynor-Kaplan, A. E. Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem. J. 315, 775-779 (1996).
100. Sato, S. et al. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J. Exp. Med. 180, 2101-2111 (1994).
101. Guinamard, R., Fougereau, M. & Seekinger, P. The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS. Scand. J. Immunol. 45, 587-595 (1997).
102. Bunnell, S. C. et al. Identification of Itk/Tsk Src homology domain ligands. J. Biol. Chem. 271, 25646-25656 (1996).
103. Machide, M., Mano, H. & Todokoro, K. Interleukin-3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 11, 610-625 (1995).
104. Takahashi-Tezuka, M. et al. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene 14, 2273-2282 (1997).
105. Yablonski, D., Kadlecek, T. & Weiss, A. Identification of a phospholipase Cγ1 (PLC-γ1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-γ1 and NFAT. Mol. Cell. Biol. 21, 4208-4218 (2001).
106. Ramos Morales, F., Druker, B. J. & Fischer, S. Vav binds to several SH2/SH3-containing proteins in activated lymphocytes. Oncogene 9, 1917-1923 (1994).
107. Kranewitter, W. J. & Gimona, M. N-terminally truncated Vav induces the formation of depolymerization-resistant actin filaments in NIH 3T3 cells. FEBS Lett. 455, 123-129 (1999).
108. Katzav, S., Martin, Z. D. & Barbacid, M. Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8, 2283-2290 (1989).
109. Adams, J. M., Houston, H., Allen, J., Lints, T. & Harvey, R. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 7, 611-618 (1992).
110. Schuebel, K. E. et al. Isolation and characterization of murine Vav-2, a member of the Vav family of proto-oncogenes. Oncogene 13, 363-371 (1996).
111. Trenkle, T., McClelland, M., Adlkofer, K. & Welsh, J. Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors. Gene 245, 139-149 (2000).
112. Fruman, D. A., Satterthwaite, A. B. & Witte, O. N. Xid-like phenotypes: a B-cell signalosome takes shape. Immunity 13, 1-3 (2000).
113. Rawlings, D. J. et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-361 (1993).
114. DeFranco, A. L. Vav and the B-cell signalosome. Nature Immunol. 2, 482-484 (2001).
115. Schaeffer, E. M. et al. Requirement for Tec kinases Rlk and Itk in T-cell receptor signaling and immunity. Science 284, 638-641 (1999).
116. Ebinu, J. O. et al. RasGRP links T-cell receptor signalling to ras. Blood 95, 3199-3203 (2000).
117. Fackler, O. T., Luo, W., Geyer, M., Alberts, A. S. & Peterlin, B. M. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell. 3, 729-739 (1999).